Thus, these data support the model that TJ disruption results from increased vascular permeability that takes place during extreme neovascularization in AD, likely triggered by production of APP, abeta or perhaps abeta*56 during amyloidogenesis. This evidence concerns the gene APP and Alzheimer disease.